IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
This study is currently recruiting participants.
Verified May 2013 by Janssen Biotech, Inc.
Sponsor:
Janssen Biotech, Inc.
Information provided by (Responsible Party):
Janssen Biotech, Inc.
ClinicalTrials.gov Identifier:
NCT01314118
First received: March 4, 2011
Last updated: May 29, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | July 2015 |
| Estimated Primary Completion Date: | October 2014 (Final data collection date for primary outcome measure) |